dsip umich Welcome to D-SIP 2025-Project Showcase U-M Office of University Development
Description
This decreased threshold was significantly attenuated in the BPC10, BPC20, BPC40 and morphine groups at the same time
Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy
SynaPep BPC-157 is an advanced oral peptide therapy designed to support tissue repair, calm persistent inflammation, and promote more efficient recovery
Dr Chan obtained his Bachelor of Medicine and Bachelor of Surgery with Honours from Monash University in Melbourne, Australia, in 2012
